{"SPADE_UN_08096": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 7001924 B2", "Patent Link": "http://www.lens.org/lens/patent/US_7001924_B2", "Patent Type": "Granted Patent", "Publication Date": "2006-2-21", "Family Info": "EP1435932A2,EP1435932A4,US20030134904,WO2003024407A2,WO2003024407A3", "Patent Title": "Inhibitors of RNase P proteins as antibacterial compounds.", "Abstract": "The present invention features compounds useful for inhibiting RNase P activity. These compounds can be used as therapeutics for treating or preventing a variety of bacterial infections. The compounds belong to several classes including mono- and bis-guanylhydrazones, guanylhydrazone mimetics, and benzothiazolium compounds. Exemplary compounds are compounds of formula I: \nYâ€”(NRâ€²)kâ€”U1â€”(NRâ€³)Iâ€”Aâ€”(NR1)mâ€”U2â€”(NR2)nâ€”Zâ€ƒâ€ƒI with substituents as described herein."}], "Sequence Information": {"SPADE ID": "SPADE_UN_08096", "Sequence": "HRIKKNDEFSRVFRVLSVSKKIGNAVTRNRVKRLIRTSITELKDEIDYVIIARKPCAEMTYEQVKGSLW", "Sequence Length": 69, "Peptide Name": "Sequence 93 from Patent US 7001924", "Source": "Synthetic construct", "Biological Activity": ["Antimicrobial"], "Frequent Amino Acids": "KRI", "Absent Amino Acids": "OU", "Basic Residues": 17, "Acidic Residues": 8, "Hydrophobic Residues": 28, "Polar Residues": 43, "Positive Residues": 17, "Negative Residues": 8, "Mass": 8135.43, "PI": 10.17, "Net Charge": 9, "Hydrophobicity": -0.49, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_18523", "Similarity": 0.8, "Sequence": "HRIKRSDEFSRVLSVSKKIGNAVTRNRVKRLIRTISDYVIVKGSL"}, {"SPADE_ID": "SPADE_N_05780", "Similarity": 0.7164179104477612, "Sequence": "MKKHRIKKNDERQTVFQKGKSNANRQRWYQLDKEEQPNFRIGLSVSKKIGNAWRNRIKRMIRQSITELKDEIDSGKDPVIAHKPCAEMTYEEIIKKS"}, {"SPADE_ID": "SPADE_UN_18524", "Similarity": 0.6956521739130435, "Sequence": "HRIKKNDEFQRIGLSVSKKIGNAVVRNRIKRMIRQIDDFVILKKSL"}]}}}